GlassScriptPhysician profile
Khrystyna Splavnyk
NPI 1730598525
$552.94
in general payments reported to CMS, 2019-2025
14 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $284.55 | 2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $29.73 | 2025 | |
| Calyxo, INC. | $24.47 | 2025 | Cvac Aspiration System |
| Verity Pharmaceuticals INC. | $24.22 | 2025 | Tlando |
| Endo USA, INC. | $23.01 | 2025 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $22.72 | 2025 | |
| Sumitomo Pharma America, INC. | $22.20 | 2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $21.65 | 2025 | Provenge |
| Becton, Dickinson and Company | $21.54 | 2025 | Bard Urinary Drainage Bag |
| Coloplast Corp | $20.89 | 2025 | |
| Tolmar, INC. | $20.50 | 2025 | Jatenzo, Eligard |
| Philips North America LLC | $16.46 | 2025 | Uronav |
| Immunitybio, INC. | $13.97 | 2025 | |
| Boston Scientific Corporation | $7.03 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khrystyna Splavnyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.